FDA, NIH: Telehealth Key To Diversifying Trials, But Hurdles Remain

FDA and NIH are recruiting clinical trial participants via telehealth in a bid to increase the number of enrollees of color and lower socioeconomic status, according to FDA and NIH. But an FDA official told Inside TeleHealth that the lack of interstate licensing infrastructure, poor access to broadband and gaps in regulatory guidance are slowing their efforts to use digital health technologies to increase diversity among trial enrollees. NIH and FDA are scrambling to diversify the type of patients...